May 11, 2009 05:47 PM | 3
As the world frets about the swine flu virus, the scientists credited with discovering HIV urged governments and international organizations to redouble their commitment to the battle against AIDS.
Robert Gallo and Luc Montagnier, whose roles in identifying the viral cause of AIDS have been disputed over the years, came together Friday to commemorate the 25th anniversary of their discovery with a global call to action.
Acknowledging the public’s preoccupation with the unfolding H1N1 pandemic, Gallo said, "Don't forget we have a known problem…a known deadly epidemic." Some 175,000 people die from AIDS every month—about the same number of lives claimed by the 2004 Asian tsunami, he told the audience gathered at the National Press Club in Washington.
Gallo, who directs the Institute of Human Virology at the University of Maryland School of Medicine in Baltimore, said that creating an HIV vaccine should be top on the research agenda. But the challenges are significant and efforts so far have failed.
One important reason: the virus incorporates itself into a person's chromosomes a day or two after infection. "I believe we have to block [the virus] right at the gate"—in other words, develop a vaccine that stimulates the body to produce antibodies that prevent HIV from ever entering cells, Gallo explained to ScientificAmerican.com in an interview following the news conference.
HIV's ability to hide out in the host cell's genetic material, a phenomenon called "latent infection," is also a major barrier to finding a cure, according to virologist Michael Emerman of the Fred Hutchinson Cancer Research Center in Seattle. But developing drugs that could either stimulate the immune system to attack these latently infected cells, or prompt the cells to begin churning out viruses so the immune system spots and attacks them, might help get around this problem, he notes.
For his part, Montagnier, president of the World Foundation for AIDS Research and Prevention, said, "We are not dead in AIDS research." The virus continues spreading and we still have no vaccine or cure, he added.
Gallo's and Montagnier's joint appearance comes less than a year after Montagnier and his colleague Françoise Barré-Sinoussi from the Pasteur Institute in Paris received the Nobel Prize in Physiology or Medicine for their discovery of HIV. Many saw the Nobel Assembly's omission of Gallo as an outright snub, as he is commonly considered the co-discoverer of HIV alongside Montagnier. The French team was the first to isolate the virus, but it was Gallo who established the link between HIV and AIDS.
Gallo and Montagnier seem to have put the past aside. "I was surprised; I was disappointed" about the Nobel, Gallo said over the phone, as he and Montagnier drove to lunch together after the news conference. But, he said, "We are friends and we are colleagues that discuss things with some regularity." Chiming in from the background, Montagnier said that he was not in the position to challenge the Nobel committee's position.
The duo has published several articles explaining their complimentary contributions to HIV research – including a 1988 Scientific American piece in which they wrote, "contributions from our laboratories in roughly equal proportions-had demonstrated that the cause of AIDS is a new human retrovirus."
For more on the HIV/AIDS epidemic, see our In-Depth Report
Image of Montagnier (left) and Gallo (right), courtesy of The University of Maryland School of Medicine
Tags:
AIDS,
HIV,
Montagnier,
Gallo,
discovery
More News Blog:
Next: Drug company swag sways med students
Previous: Islands of species richness
Deadline: Jun 30 2013
Reward: $1,000,000 USD
This is a Reduction-to-Practice Challenge that requires written documentation and&
Deadline: Aug 31 2013
Reward: $100,000 USD
The Geoffrey Beene Foundation Alzheimer’s Initiative (GBFAI) is launching the 2013 Geoffrey Beene Global NeuroDiscovery Challenge whose
Powered By: 
3 Comments
Add CommentI for one, don't think that a vaccine or treatment to neutralize those infected with HIV is going to appear anytime soon. Like diabetes, cancer and certain other diseases, it has become a source of significant revenue whose eradication would severely negatively impact both the major pharmaceutical companies who sell the medications and the public health officials who have made administrative careers from HIV; and once retired, astonishingly frequently join the aforementioned pharmaceutical companies for significant salaries.
Reply | Report Abuse | Link to thisMoreover, in the US at least, HIV currently occupies an ecological and economic niche largely in what some have characterized as "disposable populations"-- sexual minorities without civil rights condemned by State tolerated and often support interpretation of Divine Fiat, poor Blacks, and "morally reprehensible" IV drug addicts. And despite some occasional theatrics, none of these populations have the power to break the economic desirability of sustaining the status quo.
Additionally, prestige driven health research--such as the race for a polio vaccine and insulin--has historically not be a motivation in sexually transmitted maladies. Syphilis was never a battle between a bacterium and man, but rather a battle between man and society. Noticeably, when the US had a unique epidemiological opportunity about a decade ago to eradicate syphilis for the grand sum of $15M, it was not forth coming from the US government or from any private group. Several anthropological studies on syphilis--perhaps the best paradigm for HIV--have indicated that penicillin was not recommended for its cure until 1947-- long after the drug was used for numerous other infections. Indeed, the Tuskegee Syphilis Study was deemed so important by the then, USPublic Health--forerunner of the CDC which was founded by the some of the same men--that it ran until 1972 and didn't treat the infects. Only then was the "scientific importance" of watching people die of syphilis stopped because of a news lead and the subsequent lack of faith in the institution, rendering it void.
Given these facts, I rather think that the min. $50,000 + per annum, per infectee of HIV, to which the ancillary costs of drug toxicities such as cardio IM & liver/internal organ failure from endless chemotherapies, will continue to generate increasing hospital and medical revenues over the next decades, indicate to me that neither a vaccine nor blocker for HIV is desirable at this time in a profit based system such as the US.
There are many natural ways to rid your body of HIV. In contrast with the traditional antiviral cocktails of medicine today, which cost thousands, have severe side effects, and comes with the double edged sword delema,meaning if the virus doesn’t kill you the cocktails will, this medicine is all natural.Please visit this site for the full information about this subject……http://pushgood-nomorehiv.blogspot.com/
Reply | Report Abuse | Link to thisDr. Gallo
Reply | Report Abuse | Link to this